On May 20th, psychedelic company “Numinus” will begin trading under the symbol NUMI after completing an RTO transaction with Salvation Biosciences. Numinus will begin trading on the Canadian TSX Venture exchange, making the company one of a growing number of publicly traded psychedelic companies.

“We are in this for the long run and the right reasons. We are advancing psychedelic laboratory testing, therapy and research and hope to create a lifelong relationship between Numinus and our clients in their journey to heal and be well.” As stated on their website, the company also plans to open a purpose built facility once proper legal channels are established.

Numinus has been at the forefront of investor conversations when it comes to the top companies to keep an eye on. Based in Nanaimo, BC, the company’s research laboratory is revenue generating and considered one of the largest in Western Canada.

For investors looking at the growing psychedelic market, Numinus is sure to be in the news for the foreseeable future.